The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells

A N Orekhov1, V V Tertov, E M Pivovarova

  • 1Institute of Experimental Cardiology, Cardiology Research Center, Moscow, Russia.

Cardiology
|April 2, 1998
PubMed

Insights

Amlodipine and verapamil show antiatherogenic effects by reducing cholesterol and protein synthesis in cells. Propranolol worsened these parameters, while perindoprilat had no effect.

Area of Science:

  • Cardiovascular Pharmacology
  • Atherosclerosis Research

Background:

  • Atherosclerosis is a complex disease involving lipid accumulation and smooth muscle cell proliferation.
  • Antihypertensive agents are widely used, but their direct effects on atherosclerotic processes require further investigation.

Purpose of the Study:

  • To evaluate the antiatherogenic and antiatherosclerotic potential of four antihypertensive drugs: amlodipine, verapamil, propranolol, and perindoprilat.
  • To compare the effects of these agents on human aortic smooth muscle cells and in an ex vivo model.

Main Methods:

  • Human aortic smooth muscle cells and serum from patients with coronary atherosclerosis were used in cell culture experiments.
  • Intracellular cholesterol content, cell proliferation, and protein synthesis were measured.
  • An ex vivo model was employed to confirm antiatherosclerotic actions.

Main Results:

  • Amlodipine and verapamil significantly inhibited serum-induced increases in cholesterol, proliferation, and protein synthesis.
  • Propranolol increased these parameters, indicating a potentially detrimental effect.
  • Perindoprilat demonstrated a neutral effect on all measured atherosclerotic parameters.
  • Amlodipine exhibited a greater antiatherosclerotic effect than verapamil in ex vivo studies.

Conclusions:

  • Amlodipine and verapamil possess significant antiatherogenic and antiatherosclerotic properties.
  • The antiatherosclerotic effect of amlodipine is more pronounced than that of verapamil.
  • Propranolol may have detrimental effects on atherosclerotic processes, while perindoprilat appears neutral.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...